Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

VEGFR1/Flt-1 Antibody (MAB0702), Biotin, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP221963B

Catalog No. NBP221963B


Only null left
Add to Cart

Description

Description

VEGFR1/Flt-1 Monoclonal specifically detects VEGFR1/Flt-1 in Human, Mouse samples. It is validated for Western Blot.
Specifications

Specifications

VEGFR1/Flt-1
Monoclonal
Biotin
PBS with 0.05% Sodium Azide
FLT1
This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse immunized with purified extracellular domain of recombinant human VEGFR1. VEGFR-1 ( Antagonistic) EC domain, AAC50060.
100 μL
Primary
This antibody recognizes both human and mouse VEGFR1 in western blot. It shows no cross-reactivity with human or mouse VEGFR2.
Store at 4C in the dark.
Western Blot
MAB0702
Western Blot
EC 2.7.10, EC 2.7.10.1, FLT, FLT-1, Fms-like tyrosine kinase 1, fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascularpermeability factor receptor), FRT, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, vascular endothelial growth factor receptor 1, Vascular permeability factor receptor, VEGFR1, VEGFR-1
Mouse
Affinity Purified
Angiogenesis, Cancer, Cellular Markers, Endothelial Cell Markers, HIF Target Genes, Hypoxia, Myeloid derived Suppressor Cell, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
2321
Human, Mouse
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.